electroCore to Participate at the Planet MicroCap Showcase
electroCore (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, has announced its participation in the upcoming Planet MicroCap Showcase at the Paris Hotel & Casino in Las Vegas on April 23 & 24, 2025.
CEO Dan Goldberger will deliver a group presentation on Wednesday, April 23, 2025, at 1:30 p.m. PT and will be available for one-on-one meetings throughout the event. Interested investors can schedule meetings through Planet MicroCap or by contacting electroCore's investor relations at ecor@fnkir.com.
electroCore (Nasdaq: ECOR), un'azienda bioelettronica nel settore della medicina e del benessere in fase commerciale, ha annunciato la sua partecipazione al prossimo Planet MicroCap Showcase che si terrà presso il Paris Hotel & Casino di Las Vegas il 23 e 24 aprile 2025.
Il CEO Dan Goldberger terrà una presentazione di gruppo mercoledì 23 aprile 2025 alle 13:30 PT e sarà disponibile per incontri individuali durante tutta la durata dell'evento. Gli investitori interessati possono fissare appuntamenti tramite Planet MicroCap o contattando le relazioni con gli investitori di electroCore all'indirizzo ecor@fnkir.com.
electroCore (Nasdaq: ECOR), una empresa de medicina bioelectrónica y bienestar en etapa comercial, ha anunciado su participación en el próximo Planet MicroCap Showcase en el Paris Hotel & Casino de Las Vegas los días 23 y 24 de abril de 2025.
El CEO Dan Goldberger ofrecerá una presentación grupal el miércoles 23 de abril de 2025 a la 1:30 p.m. PT y estará disponible para reuniones individuales durante todo el evento. Los inversores interesados pueden programar reuniones a través de Planet MicroCap o contactando a las relaciones con inversionistas de electroCore en ecor@fnkir.com.
electroCore(나스닥: ECOR)는 상업 단계의 바이오일렉트로닉 의학 및 웰니스 회사로서, 2025년 4월 23일과 24일 라스베이거스의 Paris Hotel & Casino에서 개최되는 Planet MicroCap Showcase에 참가한다고 발표했습니다.
CEO Dan Goldberger는 2025년 4월 23일 수요일 오후 1시 30분(태평양 시간)에 그룹 발표를 진행하며, 행사 기간 내내 1:1 미팅도 진행할 예정입니다. 관심 있는 투자자는 Planet MicroCap를 통해 또는 electroCore 투자자 관계팀 ecor@fnkir.com으로 연락하여 미팅을 예약할 수 있습니다.
electroCore (Nasdaq : ECOR), une entreprise de médecine bioélectronique et de bien-être en phase commerciale, a annoncé sa participation au prochain Planet MicroCap Showcase qui se tiendra au Paris Hotel & Casino de Las Vegas les 23 et 24 avril 2025.
Le PDG Dan Goldberger donnera une présentation de groupe le mercredi 23 avril 2025 à 13h30 PT et sera disponible pour des réunions individuelles tout au long de l'événement. Les investisseurs intéressés peuvent planifier des rendez-vous via Planet MicroCap ou en contactant les relations investisseurs d’electroCore à l’adresse ecor@fnkir.com.
electroCore (Nasdaq: ECOR), ein Unternehmen für bioelektronische Medizin und Wellness im kommerziellen Stadium, hat seine Teilnahme an der bevorstehenden Planet MicroCap Showcase im Paris Hotel & Casino in Las Vegas am 23. und 24. April 2025 angekündigt.
CEO Dan Goldberger wird am Mittwoch, den 23. April 2025, um 13:30 Uhr PT eine Gruppenpräsentation halten und während der gesamten Veranstaltung für Einzelgespräche zur Verfügung stehen. Interessierte Investoren können Meetings über Planet MicroCap oder durch Kontaktaufnahme mit der Investor Relations von electroCore unter ecor@fnkir.com vereinbaren.
- None.
- None.
ROCKAWAY, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the Planet MicroCap Showcase taking place at the Paris Hotel & Casino in Las Vegas on April 23 & 24, 2025.
Dan Goldberger, CEO, will host a group presentation on Wednesday, April 23, 2025 at 1:30 p.m. PT and host one-on-one meetings throughout both days.
To schedule a one-on-one meeting with Mr. Goldberger, investors are encouraged to reach out to Planet MicroCap or electroCore’s investor relations at ecor@fnkir.com.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.
Contact
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com
FAQ
When is electroCore (ECOR) presenting at the Planet MicroCap Showcase 2025?
How can investors schedule meetings with electroCore (ECOR) management at the Planet MicroCap Showcase?
What type of company is ECOR and where will they be showcasing?
Which electroCore executive will be presenting at the 2025 Planet MicroCap Showcase?
